The optimal way to consume Cannabis and Cannabinoids as medicine
A worldwide campaign informs in six lectures on Medical Cannabis – the campaign is financed by crowdfunding and has already collected nearly $ 20,000, only four days left to donate
However, the cannabinoids THC and CBD exist in the cannabis plant mostly under the form of the so called carboxylic acids. Heating converts the THC acids (THCA) into phenolic THC, and the CBD-carboxylic acid (CBDA) into phenolic CBD (so called “decarboxylation”). Most of the therapeutic effects of these compounds are only exerted by the phenolic THC and CBD. A few seconds at high temperatures are sufficient for this process to occur. However, at lower temperatures, the heating time required increases to minutes or hours. Nonetheless, if THC is heated for too long, it will further be oxidized into cannabinol (CBN), which only exerts insignificant pharmacological effects
MCD’s newest lecture on cannabis as medicine explains the best ways to ‚activate’ cannabinoids in order to achieve the highest effect out of its medicinal compounds. This lecture is part of a series funded by the crowdfunding campaign „Say Yes to Cannabis as Medicine“ – igg.me/at/medical-cannabis-declaration
Lecture topics range from what is cannabis, to how it operates within the human body, along with its historical and current use as medicine. For more information, visit us at medical-cannabis-declaration.org
Medical Cannabis Declaration (MCD) kicked off a crowdfunding campaign at the platform Indiegogo to finance videos and online lectures in the ten most spoken languages of the world for its information campaign. So far the crowdfunding raised nearly 20,000 $ with the campaign running for another four days.
One of the campaign’s goals is to give patients better access to reliable information on cannabis as medicine. Still, only 10 out of 200 countries in the world grant their citizens access to cannabis for medical use. Another 20 countries established regulations that make cannabis as medicine accessible only in a few special cases, while in more than 150 countries legal access to this treatment remains unavailable.
MCD would like to thank our Platinum donor Dr. Bronner (USA), along with crowdfunding Gold level MH medical hemp (Germany), and silver level donors Canah (Romania) CBDepot.eu (Slovakia), Green Snake Hemp Juice (Germany) and HempConsult (Germany) for their contribution. More information on the donors: http://medical-cannabis-declaration.org/...
The campaign will post about its progress on Twitter using the Hashtag #YesToMedicalCannabis
About Medical Cannabis Declaration e.V. (MCD)
The Medical Cannabis Declaration (MCD) is an online platform founded on 16 February 2013 in Ruethen, Germany, established by worldwide medical professionals and patients who believe that the access to cannabis should not be determined by geography. MCD aims at promoting safe and regular prescription and use of medical cannabis, globally. The charity wants to be part of a growing movement to change the negative perception on cannabis to assure its real medical values are recognised. We solely rely on scientific studies developed for the medical use of the cannabis plant. Visit us at: www.medical-cannabis-declaration.org/...
You can download a map showing legal access to medical cannabis around the world as well as campaign logos in high resolution at www.medical-cannabis-declaration.org/...
For crowdfunding campaign:
For general information:
Dr Franjo Grotenhermen
Responsible under press legislation (V.i.S.d.P.):
Medical Cannabis Declaration e. V.
Am Mildenweg 6, 59602 Ruethen, Germany
Dr Franjo Grotenhermen
nova-Institut für politische und ökologische Innovation GmbH
Press releases you might also be interested in
Weitere Informationen zum Thema "Medizintechnik":
Unternehmen setzen auf KI und Maschine Learning
Eine von Sophos unterstütze aktuelle IDC-Studie zeigt auf, dass 70 Prozent der Unternehmen planen, dieses Jahr Künstliche Intelligenz und Machine Learning (ML) einzusetzen, um die IT-Sicherheit zu verbessern. Für die IDC-Studie wurden im letzten Quartal 108 Unternehmen mit mehr als 1.000 Mitarbeitern befragt.Weiterlesen